[1] OTTAVIANI G, JAFFE N .The epidemiology of osteosarcoma. Cancer Treat. Res.2009;152:3-13.
[2] HATTINGER CM, FANELLI M, TAVANTI E, et al. Advances in emerging drugs for osteosarcoma.Expert Opin Emerg Drugs. 2015;20: 495-514.
[3] RAYMOND AK, JAFFE N. Osteosarcoma multidisciplinary approach to the management from the pathologist's perspective. Cancer Treat. Res.2009;152: 63-84.
[4] GOBIN B, MORICEAU G, ORY B, et al. Imatinib mesylate exerts anti-proliferative effects on osteosarcoma cells and inhibits the tumour growth in immunocompetent murine models. PLoS ONE. 2014;9: e90795.
[5] DE SC, PIETRABISSA A, MOSCA F, et al. Methylation of quercetin and fisetin, flavonoids widely distributed in edible vegetables, fruits and wine, by human liver.Int J Clin Pharmacol Ther. 2002;40: 207-212.
[6] HUANG J, LIU K, YU Y, et al. Targeting HMGB1-mediated autophagy as a novel therapeutic strategy for osteosarcoma. Autophagy.2012;8: 275-277.
[7] DUPREZ L, WIRAWAN E, VANDEN BT, et al. Major cell death pathways at a glance.Microbes Infect. 2009;11: 1050-1062.
[8] GOZUACIK D, KIMCHI A. Autophagy as a cell death and tumor suppressor mechanism.Oncogene.2004;23: 2891-2906.
[9] LIU EY, RYAN KM. Autophagy and cancer - issues we need to digest.J Cell Sci. 2012;125(Pt 10):2349-2358.
[10] BERLANGA P, MUÑOZ L, PIQUERAS M, et al. miR-200c and phospho-AKT as prognostic factors and mediators of osteosarcoma progression and lung metastasis.Mol Oncol. 2016;10: 1043-1053.
[11] LI X, WANG S, CHEN Y, et al. miR-22 targets the 3′ UTR of HMGB1 and inhibits the HMGB1-associated autophagy in osteosarcoma cells during chemotherapy.Tumor Biology.2014; 35(6):6021-6028.
[12] ZHU H, HUANG LI, ZHU S, et al. Regulation of autophagy by systemic admission of microRNA-141 to target HMGB1 in l-arginine-induced acute pancreatitis in vivo.Pancreatology. 2016;16:337-346.
[13] YANG Y, LIU Y, XUE J, et al. MicroRNA-141 Targets Sirt1 and Inhibits Autophagy to Reduce HBV Replication.Cell Physiol Biochem.2017;41: 310-322.
[14] XU H, MEI Q, XIONG C, et al. Tumor-suppressing effects of miR-141 in human osteosarcoma.Cell Biochem Biophys. 2014;69:319-325.
[15] CUI SQ, WANG H. MicroRNA-144 inhibits the proliferation, apoptosis, invasion, and migration of osteosarcoma cell line F5M2.Tumour Biol.2015;36: 6949-6958.
[16] LIU K, HOU Y, LIU Y, et al. LncRNA SNHG15 contributes to proliferation, invasion and autophagy in osteosarcoma cells by sponging miR-141. J Biomed Sci.2017; 24: 46.
[17] MEI Q, LI F, QUAN H, et al. Busulfan inhibits growth of human osteosarcoma through miR-200 family microRNAs in vitro and in vivo.Cancer Sci.2014;105: 755-762.
[18] WHITE E, KARP C, STROHECKER AM, et al. Role of autophagy in suppression of inflammation and cancer. Curr Opin Cell Biol. 2010;22(2):212-217.
[19] KANG R, ZEH HJ, LOTZE MT, et al. The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ. 2011; 18(4):571-580.
[20] ZHONG Y, WANG QJ, LI X, et al. Distinct regulation of autophagic activity by Atg14L and Rubicon associated with Beclin 1–phosphatidylinositol-3-kinase complex.Nature Cell Biology.2009; 11(6):468-476.
[21] FIMIA GM, STOYKOVA A, ROMAGNOLI A, et al. Ambra1 regulates autophagy and development of the nervous system. Nature.2007;447: 1121-1125.
[22] MAIURI MC, LE TG, CRIOLLO A, et al. Functional and physical interaction between Bcl-XL and a BH3-like domain in Beclin-1. EMBO J.2007; 26(10):2527-2539.
[23] LUO S, GARCIA AM, ZHAO R, et al. Bim Inhibits Autophagy by Recruiting Beclin 1 to Microtubules. Molecular Cell. 2012; 47(3):359-370.
[24] KIM J,KUNDU M, VIOLLET B , et al. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol. 2011;13(2):132-141.
[25] YORIMITSU T, KLIONSKY DJ. Eating the endoplasmic reticulum: quality control by autophagy. Trends Cell Biol. 2007; 17(6):279-285.
[26] AITA VM, LIANG XH, MURTY VV, et al. Cloning and Genomic Organization of Beclin 1, a Candidate Tumor Suppressor Gene on Chromosome 17q21. Genomics.1999;59(1):60-65.
[27] TAO H, CHEN F, LIU H, et al.Wnt/β-catenin signaling pathway activation reverses gemcitabine resistance by attenuating Beclin1-mediated autophagy in the MG63 human osteosarcoma cell line.Mol Med Rep.2017;16: 1701-1706.
[28] MIZUSHIMA N, YOSHIMORI T, OHSUMI Y. The role of Atg proteins in autophagosome formation.Annu Rev Cell Dev Biol.2011;27: 107-132.
[29] LAPLANTE M, SABATINI D. mTOR Signaling in Growth Control and Disease.Cell. 2012;149(2):274-293.
[30] ZONCU R, EFEYAN A, SABATINI DM. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol. 2011;12(1):21-35.
[31] BEAUCHAMP EM, PLATANIAS LC .The evolution of the TOR pathway and its role in cancer.Oncogene. 2013;32(34): 3923-3932.
[32] JUNG CH, JUN CB, RO SH, et al. ULK-Atg13-FIP200 Complexes Mediate mTOR Signaling to the Autophagy Machinery.Mol Biol Cell. 2009;20(7):1992-2003.
[33] PATTINGRE S, ESPERT L, BIARD PM, et al. Regulation of macroautophagy by mTOR and Beclin 1 complexes. Biochimie.2008;90(2):313-323.
[34] WEI Y, PATTINGRE S, SINHA S, et al. JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy. Molecular Cell.2008;30(6):678-688.
[35] GUO ZS ,LIU Z, BARTLETT DL, et al. Life after death: targeting high mobility group box 1 in emergent cancer therapies.Am J Cancer Res. 2013;3(1):1-20.
[36] HUANG J, NI J D, LIU K, et al. HMGB1 promotes drug resistance in osteosarcoma.Cancer Res.2012; 72: 230-238.
[37] LEVY DE, DARNELL JE. STATS: Transcriptional control and biological impact. Nat Rev Mol Cell Biol.2002;3(9):651-662.
[38] YU H, PARDOLL D, JOVE R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer. 2009;9(11):798-809.
[39] YOU LK, WANG ZG, LI HS, et al. The role of STAT3 in autophagy.Autophagy.2015;11: 729-739.
[40] LIU KS, REN TT, HUANG Y, et al. Apatinib promotes autophagy and apoptosis through VEGFR2/STAT3/BCL-2 signaling in osteosarcoma.Cell Death Dis.2017;8:e3015.
[41] THOMPSON LD.Osteosarcoma.Ear Nose Throat J.2013; 92(7):288, 290.
[42] KIM M, JUNG J, CHOI S, et al.GFRA1 promotes cisplatin-induced chemoresistance in osteosarcoma by inducing autophagy.Autophagy.2017;13: 149-168.
[43] CAO Z, LIVAS T, KYPRIANOU N. Anoikis and EMT: Lethal "Liaisons" during Cancer Progression.Crit Rev Oncog. 2016; 21(3-4):155-168.
[44] YANG J, ZHENG Z, YAN X, et al. Integration of autophagy and anoikis resistance in solid tumors.Anat Rec (Hoboken). 2013;296:1501-1508.
[45] WHITE E, MEHNERT JM, CHAN CS. Autophagy, metabolism, and cancer. Clin Cancer Res. 2015;21(22):5037-5046.
[46] FAN X, ZHANG H, CHENG Y, et al. Double Roles of Macrophages in Human Neuroimmune Diseases and Their Animal Models.Mediators Inflamm.2016;2016: 8489251.
[47] APETOH L, GHIRINGHELLI F, TESNIERE A, et al. Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med.2007; 13(9):1050-1059.
[48] URGESS DJ. Apoptosis: Refined and lethal.Nat Rev Cancer. 2013;13: 79.
[49] ZIMMERMANN KC, BONZON C, GREEN DR. The machinery of programmed cell death.Pharmacol Ther.2001; 92(1):57-70.
[50] VERESOV VG, DAVIDOVSKII AI. Activation of Bax by joint action of tBid and mitochondrial outer membrane: Monte Carlo simulations. Eur Biophys J. 2009;38(7):941960.
[51] DING L, HE S, SUN X. HSP70 desensitizes osteosarcoma cells to baicalein and protects cells from undergoing apoptosis. Apoptosis.2014;19(8):1269-1280.
[52] ZHANG Y, CHEN P, HONG H, et al.JNK pathway mediates curcumin-induced apoptosis and autophagy in osteosarcoma MG63 cells.Exp Ther Med.2017;14: 593-599.
|